MSB 3.21% $1.13 mesoblast limited

Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-33

  1. 7,859 Posts.
    lightbulb Created with Sketch. 1350
    Lol.

    I never said they wouldn't get more funds, just that it would get more difficult. Each cap raise is at lower and lower prices with more dilution for the shareholders - you guys!

    I never said they wouldn't be able to resubmit - I'm just worried they won't get approval, which is really what they need.

    And I don't know who said they wouldn't get the facility approved, I would hope they would be able to manufacture the product properly.

    None of this has derisked the company. MSB is ticking boxes that need to be ticked, absolutely, but none of these are the actual hurdle that lays ahead - where all the money lies.

    Mocking me, or questioning my intentions, or questioning my credentials doesn't change any of this. Go right ahead!

    At the end of the day the FDA will decide based on the data they are given.

    Fingers crossed they make it this time.
    Last edited by DocMcstuffins: 26/05/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.